Name
G781 - Justice, Equity, Diversity & Inclusion (JEDI) in Practice (Panel Presentation and Discussion)
Date & Time
Tuesday, May 3, 2022, 11:45 AM - 12:30 PM
Description

A discussion of just released FDA Guidance for Industry (APRIL 2022): 

Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials

Practical ways to apply diversity and inclusion principles in clinical research.

 

Session Chair: Steve Wimmer

Learning Objectives
  1. Describe and discuss implications of the April 2022 FDA Draft Guidance to Industry on DEI.
  2. Explain how diversity and inclusion affect clinical research.
  3. Describe how members of disadvantaged populations think about diversity and inclusion.
  4. Offer specific actions which can be taken by clinical trialists now.
Speakers
Drew Bustos - Chief Strategy Officer - Science 37
Sharon Medendorp - President and EVP - Premier Consulting (Speaker)
Mary Sophy Yohannan - Clinical Evaluation Scientist - Boston Scientific (Speaker)
Michael W. Young - Principal - biomedwoRx: Life Sciences Consulting (Speaker, Moderator, Leader)
Drew Bustos Sharon Medendorp Mary Sophy Yohannan Michael W. Young
Track
G - Special Topics
Location Name
Commonwealth